ArticleFrontiers in pharmacology2021

The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B.

Shi-Long Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.